CFTR and cystic fibrosis: Next, we sought to better characterize and differentiate the dual roles of VX-445 as a CFTR corrector and potentiator using HNE cultures derived from non-CF individuals and those homozygous for the F508del CFTR mutation (F508del-HNE).